Literature DB >> 7819208

Competitive triplex/quadruplex equilibria involving guanine-rich oligonucleotides.

W M Olivas1, L J Maher.   

Abstract

Oligonucleotide-directed triple helix formation in the purine motif involves the binding of guanine-rich oligonucleotides to duplex DNA. Although this approach has been proposed for in vivo gene inhibition, triple helix formation by guanine-rich oligonucleotides is severely inhibited by physiological concentrations of certain monovalent cations (M+), especially K+. To clarify the mechanism of this inhibition, electrophoretic gel mobility shift titrations were performed to analyze the formation and stability of a purine motif triple helix in the presence of M+ and to monitor oligonucleotide aggregation under these conditions. M+ inhibition of triplex formation exhibited a concentration and ionic radius dependence that correlates with the ability of M+ to stabilize guanine quartet structures. In the presence of inhibitory [M+], guanine-rich oligonucleotides formed aggregates having characteristics consistent with the involvement of guanine quartets. The inhibitory effects of K+ on triplex formation could not be reversed by addition of the physiological polyamines spermidine3+ or spermine4+. M+ reduced the equilibrium concentration of the triplex primarily by decreasing the rate of triplex formation, but M+ also caused a detectable increase in the rate of triplex dissociation. Together, these results suggest that triplex inhibition under physiological ionic conditions is caused by competing equilibria wherein guanine-rich oligonucleotides form aggregates involving guanine quartets. Approaches to destabilizing aggregates of guanine-rich oligonucleotides under physiological conditions will be required before in vivo applications can be realistically considered.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7819208     DOI: 10.1021/bi00001a034

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  Efficient triple helix formation by oligodeoxyribonucleotides containing alpha- or beta-2-amino-5-(2-deoxy-D-ribofuranosyl) pyridine residues.

Authors:  P J Bates; C A Laughton; T C Jenkins; D C Capaldi; P D Roselt; C B Reese; S Neidle
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

Review 2.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

3.  Cleavage of double-stranded DNA by 'metalloporphyrin-linker-oligonucleotide' molecules: influence of the linker.

Authors:  P Bigey; G Pratviel; B Meunier
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

4.  Triplex formation with alpha anomers of purine-rich and pyrimidine-rich oligodeoxynucleotides.

Authors:  S B Noonberg; J C François; D Praseuth; A L Guieysse-Peugeot; J Lacoste; T Garestier; C Hélène
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

5.  Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.

Authors:  Faye A Rogers; Janice A Lloyd; Meetu Kaushik Tiwari
Journal:  Artif DNA PNA XNA       Date:  2014

6.  Overcoming potassium-mediated triplex inhibition.

Authors:  W M Olivas; L J Maher
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

7.  Effect of competing self-structure on triplex formation with purine-rich oligodeoxynucleotides containing GA repeats.

Authors:  S B Noonberg; J C François; T Garestier; C Hélène
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

8.  Poly(L-lysine)-graft-dextran copolymer: amazing effects on triplex stabilization under physiological pH and ionic conditions (in vitro).

Authors:  A Ferdous; H Watanabe; T Akaike; A Maruyama
Journal:  Nucleic Acids Res       Date:  1998-09-01       Impact factor: 16.971

9.  Binding of DNA oligonucleotides to sequences in the promoter of the human bc1-2 gene.

Authors:  W M Olivas; L J Maher
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

Review 10.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.